CLINICAL CRITERIA THAT EXCLUDE METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS FROM PARTICIPATING IN CLINICAL TRIALS: RETROSPECTIVE ANALYSES IN A COMMUNITY-BASED HOSPITAL

被引:0
|
作者
Alonso-Jaudenes, Guillermo [1 ]
Garcia-Campelo, Rosario [1 ]
Sande, Laura [1 ]
Roldan, Ana [1 ]
Anton Aparicio, Luis [1 ]
Fernandez, Natalia [1 ]
机构
[1] CHUA Coruna, La Coruna, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1279 / S1279
页数:1
相关论文
共 50 条
  • [1] Meta-analyses of clinical trials in patients with non-small cell lung cancer
    Kovac, V
    Smrdel, U
    NEOPLASMA, 2004, 51 (05) : 334 - 340
  • [2] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Pharmacogenomic applications in the management of Non-Small Cell Lung Cancer (NSCLC): from clinical trials to clinical practice
    Simon, George
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S302 - S304
  • [4] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN MEXICO
    Flores-Caballero, M. A.
    Lugo-Martinez, G.
    Rodriguez-Cid, J. R.
    Juarez-Vignon Whaley, J.
    Martinez-Herrera, J. F.
    Cruz-Zermeno, M.
    Seidman-Sorsby, A.
    Garcia-Montes, V
    Garibay-Diaz, J. C.
    Gonzalez Espinosa, I
    Hernandez-Flores, O.
    Oyervides-Juarez, V. M.
    Lopez Lopez, F.
    Gonzalez-Cisneros, P.
    Riera Sala, R.
    Alatorre-Alexander, J.
    Dorokhova, E.
    Betancur, M. A.
    Medina, S.
    Flores-Garcia, L.
    Amaya-Gutierrez, M. J.
    Rodriguez-Rosales, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S238 - S238
  • [5] Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center
    Andrew C. Tiu
    Rashmika Potdar
    Djeneba Audrey Djibo
    Muhammad Masab
    Claudia Dourado
    Medical Oncology, 2018, 35
  • [6] Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center
    Tiu, Andrew C.
    Potdar, Rashmika
    Djibo, Djeneba Audrey
    Masab, Muhammad
    Dourado, Claudia
    MEDICAL ONCOLOGY, 2018, 35 (07)
  • [7] Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials
    Cooper, Ryan A.
    Chai, Yan
    Nieva, Jorge
    JOURNAL OF CANCER POLICY, 2022, 33
  • [8] Clinical Relevance of Liquid Biopsies in Metastatic Adenocarcinoma of Non-small Cell Lung Cancer (NSCLC)
    Chougule, A.
    Chandrani, P.
    Pange, P.
    Kale, S.
    Jagtap, V.
    Noronha, V.
    Joshi, A.
    Patil, V.
    Dutt, A.
    Prabhash, K.
    Banavali, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1131 - 1131
  • [9] MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS
    Naidoo, Jarushka
    Noonan, Sinead
    Teo, Min Yuen
    Rho, Young Soo
    Clince, Janet
    Gately, Kathy
    O'Grady, Tony
    Kaye, Elaine
    Calvert, Paula
    Morris, Patrick G.
    O'Brien, Cathal
    O'Byrne, Kenneth
    Breathnach, Oscar S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1208 - S1208
  • [10] Management of locally advanced non-small cell lung cancer (NSCLC) at a community hospital: A retrospective analysis
    Spranklin, Laura Jane
    Heflin, Jon Willis
    Calvo, Alejandro R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)